Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA nod to Caplin Steriles Linezolid Injection to treat serious bacterial infections

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval

Written By Ruchika Sharma20 Sept 2025 11:30 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...

AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation

EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits

Written By Ruchika Sharma18 Sept 2025 3:39 PM IST

Denmark: Novo Nordisk has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Natco Pharma gets USFDA EIR for Kothur Pharma division

Written By Ruchika Sharma18 Sept 2025 12:52 PM IST

Hyderabad: Natco Pharma has announced that the U.S. Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) for the...

Rubicon Research Acquires 85% Stake in Arinna for Rs 176 Cr

Roche to acquire 89bio for up to USD 3.5 billion

Written By Ruchika Sharma18 Sept 2025 11:30 AM IST

Basel: Roche has announced that it has entered into a definitive merger agreement to acquire 89bio, Inc., a publicly listed clinical-stage...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Lupin bags USFDA approval for Multiple myeloma treatment

Written By Ruchika Sharma17 Sept 2025 6:19 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...

Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics

Biocon Biologics wins USFDA nod for Bosaya and Aukelso, Denosumab Biosimilars

Written By Ruchika Sharma17 Sept 2025 5:36 PM IST

Bengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the U.S. Food...

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer

Written By Ruchika Sharma17 Sept 2025 1:03 PM IST

Rahway: Merck, Daiichi Sankyo have announced that Raludotatug deruxtecan (R-DXd) has received Breakthrough Therapy Designation (BTD) from the U.S....

Granules India packaging facility in US successfully completes USFDA inspection

Lupin gets 6 USFDA observations for Nagpur facility

Written By Ruchika Sharma17 Sept 2025 11:00 AM IST

Mumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six observations at the company's...

Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated

JnJ launches Shockwave Javelin Peripheral IVL Catheter in Europe

Written By Ruchika Sharma16 Sept 2025 2:15 PM IST

Santa Clara: Johnson & Johnson has announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, a novel intravascular...

Thermo Fisher expands India footprint with Customer Experience, Bioprocess Design Centers at Genome Valley

Thermo Fisher Scientific unveils Efficient-Pro Medium (+) Insulin

Written By Ruchika Sharma16 Sept 2025 1:15 PM IST

Waltham: Thermo Fisher Scientific Inc., has unveiled the Gibco Efficient-Pro Medium (+) Insulin, a next-generation medium designed to increase...

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

Novartis, Monte Rosa Therapeutics join hands for Degraders to treat Immune-mediated diseases

Written By Ruchika Sharma16 Sept 2025 12:15 PM IST

Boston: Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based...

Language Row Costs Pharmacist: Action Ordered for Giving Wrong Medicine, Refusing Bengali

ZyVet releases generic treatment for Canine Urinary Incontinence in US

Written By Ruchika Sharma16 Sept 2025 11:25 AM IST

Pennington: ZyVet Animal Health, a generic pharmaceuticals company for animals, a wholly owned subsidiary of Zydus Pharmaceuticals (USA) Inc., itself...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok